{"schema_version":"secwatch.filing_event.v1","accession":"0000950142-22-003473","form_type":"8-K","ticker":"VTVT","cik":"0001641489","company_name":"vTv Therapeutics Inc.","filed_at":"2022-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.537131+00:00","generated_at":"2026-06-20T23:23:10.684516+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"vTv Therapeutics receives Nasdaq deficiency notice for bid price below $1.00 per share","bullets":["Received Nasdaq letter on Dec 22, 2022, citing non-compliance with Rule 5550(a)(2) due to closing bid below $1.00 for 30 consecutive business days.","Has 180 calendar days, until June 20, 2023, to regain compliance by closing bid at or above $1.00 for 10 consecutive business days.","Company is evaluating options to regain compliance; if unsuccessful, stock may be delisted from Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0000950142-22-003473","json":"https://secwatch.observer/filing/0000950142-22-003473.json","markdown":"https://secwatch.observer/filing/0000950142-22-003473.md","text":"https://secwatch.observer/filing/0000950142-22-003473.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641489/000095014222003473/0000950142-22-003473-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641489/000095014222003473/eh220315769_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T23:23:10.684516+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3385fb4979f5767782a049e0eae5d50ad8452a18","claim":"vTv Therapeutics Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"December 22, 2022, vTv Therapeutics Inc. (the “Company”) received a letter from The NASDAQ Stock Market LLC (“NASDAQ”) notifying the Company that it is not in compliance with the requirement of NASDAQ Rule 5550(a)(2) as a result of the closing bid price of the Company’s Class A common stock (“Class A Common Stock”) being below $1.00 per share for 30 consecutive business days. This notification has no effect on the listing of the Class A Common Stock on The NASDAQ Capital Market at this time. In accordance with NASDAQ Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until June","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1641489/000095014222003473/0000950142-22-003473-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}